The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
Open accessAbstract
The oral poliovirus vaccine (OPV), which prevents person-to-person transmission of poliovirus by inducing robust intestinal immunity, has been a crucial tool for global polio eradication. However, polio outbreaks, mainly caused by type 2 circulating vaccine-derived poliovirus (cVDPV2), are increasing worldwide. Meanwhile, immunodeficiency-associated vaccine-derived poliovirus (iVDPV) is considered another risk factor during the final stage of global polio eradication. Patients with primary immunodeficiency diseases are associated with higher risks for long-term iVDPV infections. Although a limited number of chronic iVDPV excretors were reported, the recent identification of a chronic type 2 iVDPV (iVDPV2) excretor in the Philippines highlights the potential risk of inapparent iVDPV infection for expanding cVDPV outbreaks. Further research on the genetic characterizations and molecular evolution of iVDPV2, based on comprehensive iVDPV surveillance, will be critical for elucidating the remaining risk of iVDPV2 during the post-OPV era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The phylogenetic tree of VP1 sequences in 157 iVDPV2 isolates. The sequence alignment was constructed using Clustal Omega, and the tree was inferred using the FastTree 2.1.10 [48] with the GTR model and gamma distribution and visualized with FigTree. Large genetic clusters of each case study are indicated by different colors, red for a chronic excretor in the United Kingdom 1995–2013 [45], blue for the environmental samples from Slovakia in 2003–2005 [43], and green for the stool and oropharyngeal samples from Israel in 2018 [46,47].](https://figures.cochat.ai/paper-figures/1fd64be8bacc4b2d8f77496c6fa5c8c2/the-molecular-evolution-of-type-2-vaccine-derived-polioviruses-in-individuals-figure-1.jpg)
![Figure 2 The frequency of synonymous and non-synonymous substitutions of the VP1 amino acid sequences from 157 iVDPV2 and 567 cVDPV2 isolates. Sequence divergence was analyzed using SNAP (Synonymous Non-synonymous Analysis Program, https://www.hiv.lanl.gov/content/sequence/SNAP/SNAP.html (accessed on 28 May 2021)) [54]. The synonymous (blue crosses) and non-synonymous substitutions (red circles) of the VDPV sequence relative to the Sabin 2 strain are depicted. (A) iVDPV2. (B) cVDPV2.](https://figures.cochat.ai/paper-figures/931302c6bde94e458cb436c111cab22f/the-molecular-evolution-of-type-2-vaccine-derived-polioviruses-in-individuals-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, cVDPV2 is most associated with cVDPV outbreaks. It is a widespread cVDPV and is responsible for most cases of AFP [89].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E., & Andino, R. (2006) · Nature · doi:10.1038/nature04388 · Cited by 1,116
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Self-citationMutational and fitness landscapes of an RNA virus revealed through population sequencing
Acevedo, A., Brodsky, L., & Andino, R. (2014) · Nature · doi:10.1038/nature12861 · Cited by 391
Burns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 309
Engineering attenuated virus vaccines by controlling replication fidelity
Vignuzzi, M., Wendt, E., & Andino, R. (2008) · Nature Medicine · doi:10.1038/nm1726 · Cited by 282
Circulating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258
Self-citationEngineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
Cited by
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“Less than 1% of polio cases result in temporary or permanent acute flaccid paralysis (AFP) [22].”
BackgroundInfluentialMohanty, A., Rohilla, R., Zaman, K., Hada, V., Dhakal, S., Shah, A., Padhi, B. K., Al‐qaim, Z. H., Altawfiq, K. J. A., Tirupathi, R., et al. (2023) · Infezioni in Medicina · doi:10.53854/liim-3102-5 · Cited by 27
Virus Evolution in Prolonged Infections of Immunocompromised Individuals
Raglow, Z., & Lauring, A. S. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae150 · Cited by 13
Kipterer, J. K., Touray, K., Akpan, G. U., Cisse, A., Babona, N., Ngobe, B., Derrick, C. Y. D., Henry, G. H., Ndoutabé, M., Seaman, V., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307001 · Cited by 9
KITAMURA, K., & Shimizu, H. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.312 · Cited by 7
Self-citation
Metadata
- Authors
- Kitamura, K., & Shimizu, H.
- Affiliations
- National Institute of Infectious Diseases (JP)
- Corresponding author
- Shimizu, Hiroyuki
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2021-07-20
- Volume
- 13
- Issue
- 7
- Pages
- 1407
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC8310373
- OpenAlex
- W3184160639
- Cited by
- 14
- References
- 70
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Agency for Medical Research and Development (JP21fk0108084)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Keywords
- primary immunodeficiency, oral polio vaccine, molecular evolution, polio eradication
- MeSH terms
- Primary Immunodeficiency Diseases, Disease Outbreaks, Humans, Poliovirus Vaccine, Oral, Vaccination, Global Health, Immunocompromised Host, Poliovirus, Evolution, Molecular, Disease Eradication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases. https://app.cochat.ai/papers/10.3390/v13071407
- The paper
- Kitamura, K., & Shimizu, H. (2021). The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases. Viruses. https://doi.org/10.3390/v13071407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.